These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18166258)

  • 1. Aripiprazole treatment for risperidone-associated tic movement: a case report.
    Su JA; Tsang HY; Chou SY; Chung PC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):899-900. PubMed ID: 18166258
    [No Abstract]   [Full Text] [Related]  

  • 2. Aripiprazole for the tic symptoms in a child receiving atomoxetine treatment for ADHD.
    Yu SH; Chou JY; Robson D; Chen VC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1355-6. PubMed ID: 20619310
    [No Abstract]   [Full Text] [Related]  

  • 3. Aripiprazole versus risperidone for treating children and adolescents with tic disorder: a randomized double blind clinical trial.
    Ghanizadeh A; Haghighi A
    Child Psychiatry Hum Dev; 2014 Oct; 45(5):596-603. PubMed ID: 24343476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of risperidone-induced tardive dyskinesia with a switch to aripiprazole monotherapy.
    Caykoylu A; Ekinci O; Yilmaz E
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):571-2. PubMed ID: 19302830
    [No Abstract]   [Full Text] [Related]  

  • 5. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A control study of aripiprazole and tiapride treatment for tic disorders in children].
    Liu YY; Chen YH; Chen H; Liu ZS
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):421-4. PubMed ID: 20540847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
    Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
    J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of symptomatic hyperprolactinemia by aripiprazole.
    Wahl R; Ostroff R
    Am J Psychiatry; 2005 Aug; 162(8):1542-3. PubMed ID: 16055781
    [No Abstract]   [Full Text] [Related]  

  • 9. Aripiprazole treatment of risperidone-induced hyperprolactinemia.
    Chen JX; Su YA; Wang SL; Bian QT; Liu YH; Wang N; Yang FD; Haile C; Kosten TR; Zhang XY
    J Clin Psychiatry; 2009 Jul; 70(7):1058-9. PubMed ID: 19653986
    [No Abstract]   [Full Text] [Related]  

  • 10. Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive-compulsive disorder.
    Lai CH
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1291-3. PubMed ID: 19706223
    [No Abstract]   [Full Text] [Related]  

  • 11. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders.
    Yoo HK; Choi SH; Park S; Wang HR; Hong JP; Kim CY
    J Clin Psychiatry; 2007 Jul; 68(7):1088-93. PubMed ID: 17685747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: a case series.
    Chen CY; Lin TY; Wang CC; Shuai HA
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):95-7. PubMed ID: 21265942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia.
    Sato G; Yoshimura S; Yamashita H; Okamoto Y; Yamawaki S
    Hiroshima J Med Sci; 2012 Dec; 61(4):75-83. PubMed ID: 23342824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of risperidone-related tardive parkinsonism with a switch to aripiprazole.
    Chen CK; Wu JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1279-80. PubMed ID: 19563854
    [No Abstract]   [Full Text] [Related]  

  • 15. Dose-dependent increase in the QTc interval in aripiprazole treatment after risperidone.
    Suzuki Y; Ono S; Fukui N; Sugai T; Watanabe J; Tsuneyama N; Someya T
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):643-4. PubMed ID: 21044656
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia.
    Miura I; Takeuchi S; Katsumi A; Kanno K; Watanabe K; Mashiko H; Niwa S
    Hum Psychopharmacol; 2012 Sep; 27(5):517-20. PubMed ID: 22927115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
    Ekinci O; Sabuncuoglu O
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):648-9. PubMed ID: 21134409
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful switch from clozapine to aripiprazole: a case report.
    Jong-Yih L
    J Clin Psychopharmacol; 2009 Feb; 29(1):93-5. PubMed ID: 19142120
    [No Abstract]   [Full Text] [Related]  

  • 19. The patient with schizophrenia taking aripiprazole: case report.
    Uzun S; Kozumplik O; Mimica N; Folnegović-Smalc V
    Psychiatr Danub; 2005 Dec; 17(3-4):234-5. PubMed ID: 16392433
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole. The newest antipsychotic agent for treatment of schizophrenia.
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2003 Feb; 41(2):14-8. PubMed ID: 12613095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.